← 返回首页
亚洲 · 区域市场 · The Financial Express

Biocon gets US FDA approval for cancer biosimilar Pebrilzo; launch expected in 2028

来源:The Financial Express · 印度 9 小时前
Biocon gets US FDA approval for cancer biosimilar Pebrilzo; launch expected in 2028
The Financial Express

详细摘要

Biocon wins US FDA approval for cancer biosimilar Pebrilzo, strengthening its oncology portfolio ahead of a 2028 launch; learn more.

在 The Financial Express 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.financialexpress.com)

推荐阅读